| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $69,177,740 ) (Continued on the next page) |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23DK127073 | Phosphatidylcholine and cholesterol ester biomarkers of type 2 diabetes and preventive treatment effects | 000 | 2 | NIH | 5/3/2022 | $163,995 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK126789 | Regulation of Adipose-Lymphatic Cross-talk | 000 | 2 | NIH | 4/21/2022 | $481,250 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL158622 | Prognostic Implications of Home-Based Blood Pressure Monitoring in Older Adults | 000 | 1 | NIH | 12/17/2021 | $118,539 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL158622 | Prognostic Implications of Home-Based Blood Pressure Monitoring in Older Adults | 002 | 2 | NIH | 6/1/2022 | $230,161 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL158622 | Prognostic Implications of Home-Based Blood Pressure Monitoring in Older Adults | 001 | 2 | NIH | 5/31/2022 | $716,785 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 000 | 2 | NIH | 4/27/2022 | $166,667 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 000 | 2 | NIH | 4/27/2022 | $208,333 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 000 | 2 | NIH | 4/27/2022 | $125,000 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 000 | 2 | NIH | 4/27/2022 | $3,811,094 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 000 | 2 | NIH | 4/27/2022 | $166,667 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 000 | 2 | NIH | 4/27/2022 | $200,000 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL158098 | Cardiac MR-Based Risk Stratification for Heart Failure and Atrial Fibrillation in HCM | 000 | 2 | NIH | 3/31/2022 | $675,383 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23MH122701 | Retinal Layer, Microvascular and Electroretinographic Determinants of Early Course Schizophrenia | 000 | 2 | NIH | 3/10/2022 | $192,024 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01MH123431 | Roles of cortical neuromodulation and offline reactivation in memory consolidation of emotionally salient visual experiences | 000 | 2 | NIH | 6/6/2022 | $350,000 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG068141 | The Trajectories and Clinical Experiences of ICD Therapy (TRACER-ICD) Study | 000 | 2 | NIH | 4/11/2022 | $680,746 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL157530 | A Multi-Dimensional Linked Registry to Identify Biological, Clinical, Health System, and Socioeconomic Risk Factors for COVID-19-Related Cardiovascular Events | 000 | 2 | NIH | 3/31/2022 | $783,813 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG071638 | Establishing Sleep Apnea as a non-cognitive phenotype of brainstem ADRD pathologies in older adults | 000 | 2 | NIH | 4/5/2022 | $1,232,581 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NR019628 | Biochemical profiling to identify cardiometabolic responsiveness to an endurance exercise intervention | 001 | 2 | NIH | 4/20/2022 | $57,443 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NR019628 | Biochemical profiling to identify cardiometabolic responsiveness to an endurance exercise intervention | 000 | 2 | NIH | 1/6/2022 | $516,981 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23AT011043 | Understanding components of mind-body exercise for physical activity engagement in metabolic syndrome | 001 | 2 | NIH | 3/18/2022 | $162,962 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K01OD031899 | Regulation of NK cell antiviral responses through alternative splicing | 001 | 2 | NIH | 6/2/2022 | $17,579 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K01OD031899 | Regulation of NK cell antiviral responses through alternative splicing | 000 | 2 | NIH | 1/13/2022 | $158,201 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS129156 | Minimally Invasive Tissues Sampling to Evaluate HIV-associated Meningitis in Zambia | 001 | 1 | NIH | 6/16/2022 | $10,000 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS129156 | Minimally Invasive Tissues Sampling to Evaluate HIV-associated Meningitis in Zambia | 001 | 1 | NIH | 6/16/2022 | -$10,000 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS129156 | Minimally Invasive Tissues Sampling to Evaluate HIV-associated Meningitis in Zambia | 000 | 1 | NIH | 6/13/2022 | $472,160 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL164561 | Cardiovascular Health of Low-Income Working-Age Adults in the US: Health Care Access, Policy, and the Pandemic | 000 | 1 | NIH | 6/9/2022 | $800,571 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | T32HL160522 | Training Program in Cardiovascular Research | 000 | 1 | NIH | 5/2/2022 | $519,020 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK128406 | The role of interferon regulatory factors in tanycytes during HFD-induced inflammation, obesity and glucose dysregulation | 000 | 1 | NIH | 5/12/2022 | $574,481 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK132284 | Structure-Guided Design of Intestine-Selective AHR Agonists for Restoration of Gut Barrier Integrity in IBD | 000 | 1 | NIH | 5/25/2022 | $705,835 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01MD016068 | Effects of DASH Groceries on Blood Pressure in Black Residents of Urban Food Deserts | 000 | 1 | NIH | 6/18/2022 | $882,572 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K08DK132413 | Lymphatic-adipocyte interactions in obesity and lymphedema | 000 | 1 | NIH | 5/16/2022 | $164,484 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21MH127483 | Developmental trajectories of brain rhythm dynamics in healthy adolescent rats: oscillatory network reconfigurations at the vulnerable age of schizophrenia prodrome | 000 | 1 | NIH | 6/15/2022 | $275,600 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21MH127479 | What the Nose Knows: Hedonic Capacity, Psychosocial Interventions and Outcomes in Schizophrenia | 000 | 1 | NIH | 4/21/2022 | $181,500 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21AI169309 | Defining the optimal type and timing of COVID-19 vaccine in pregnancy | 000 | 1 | NIH | 1/21/2022 | $216,125 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R56DK043051 | Glucose Transporter Regulation in Obesity and Diabetes | 000 | 29 | NIH | 3/21/2022 | $172,900 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL163172 | Hemopexin as an Early Biomarker of Anthracycline Cardiac Toxicity | 000 | 1 | NIH | 3/16/2022 | $672,532 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS122589 | Neuronal circuit controlling sleep-promoting ventrolateral preoptic neurons | 000 | 1 | NIH | 2/10/2022 | $391,520 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R03HL162761 | Mechanisms of Coagulation Factor XII Recruitment and Activation at the Platelet Surface | 000 | 1 | NIH | 3/8/2022 | $86,450 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS104296 | Pathophysiology of Occipital Migraine | 000 | 5 | NIH | 11/16/2021 | $344,531 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS104296 | Pathophysiology of Occipital Migraine | 001 | 5 | NIH | 3/24/2022 | $38,282 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG065554 | Scheduled Prophylactic 6-hourly IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients | 002 | 3 | NIH | 4/22/2022 | $141,020 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG065554 | Scheduled Prophylactic 6-hourly IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients | 000 | 3 | NIH | 12/22/2021 | $1,269,177 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG065554 | Scheduled Prophylactic 6-hourly IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients | 001 | 3 | NIH | 1/31/2022 | $117,017 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K99CA252044 | Therapeutic potential of FANCM for BRCA1-linked cancer | 000 | 1 | NIH | 3/4/2022 | $99,547 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA258776 | Pan-Cancer characterization of 3?UTR somatic mutations controlling tumor immune evasion | 000 | 1 | NIH | 1/26/2022 | $618,468 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21CA267088 | Gender-affirming estrogen therapy and breast cancer treatment outcome | 000 | 1 | NIH | 12/21/2021 | $245,438 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA258442 | Clinical characterization of Kidney Injury Molecule-1 (KIM-1) as a Biomarker in Renal Cell Carcinoma | 000 | 1 | NIH | 12/15/2021 | $454,247 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK133948 | CalR: A toolkit and repository for experiments of energy homeostasis using indirect calorimetry | 000 | 1 | NIH | 12/30/2021 | $432,250 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK130929 | Corticosteroids to Reduce Inflammation in Severe Pancreatitis (CRISP) | 001 | 1 | NIH | 12/15/2021 | $0 |
|
